WASHINGTON, Feb. 19, 2020 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) announces the appointment of Stephen Ray Mitchell, M.D. to its Board of Directors...
WALTHAM, Mass.--(BUSINESS WIRE)-- Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced the appointment of Scott Brun M.D. to its Board of Directors...
NEW YORK, Jan. 23, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced the appointments of Drs. Daniel Zabrowski and Ramon Mohanlal to the Company’s Board of Directors...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foghorn® Therapeutics Inc. (Foghorn), a company advancing an entirely new class of medicines targeting diseases with genetically determined dependencies in the chromatin regulatory system, today appointed Scott Biller, Ph.D., to its Board of Directors...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced the appointment of Mark Alles to the Company’s Board of Directors...
SOUTH SAN FRANCISCO, Calif., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Kezar Life SciencesInc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmune disease and cancer, today announced the appointment of Elizabeth Garner, MD, MPH to its Board of Directors. Dr. Garner is currently the Chief Medical Officer of ObsEva SA...
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced the appointment of Wendy L. Yarno as a Director of its Board of Directors...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Seres Therapeutics, Inc. (Nasdaq: MCRB) today announced the appointment of Stephen Berenson as Chairman of its Board of Directors...
RADNOR, Pa., Dec. 12, 2019 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) (“Marinus” or “Company”), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy, depression and other neuropsychiatric disorders, announced today that Elan Ezickson, has joined the Company’s Board of Directors...
The American Cancer Society (ACS) announces three new members and the newly-elected leadership officers to the Board of Directors, with all terms beginning on January 1, 2020...
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the appointment of James R. Meyers, an accomplished pharmaceutical executive with three decades of commercial experience, to the Company's Board of Directors...
WALTHAM, Mass.--(BUSINESS WIRE)-- Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small-molecule medicines that directly target RNA, announced today that it has appointed Katrine Bosley as Chairman of its Board...
![CURE Pharmaceutical [OTC: CURR] Names Canopy Rivers’ Chairman, John K. Bell, To Board of Directors](https://d112vpovu2xa8r.cloudfront.net/portal_boardprospects_hivefire_com/media/z12DJdO4gWmU2A9_100x100.jpeg)
OXNARD, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it has named John K. Bell, FCA, FCPA, ICD.D to its board of directors...
Canopy Growth Corporation ("Canopy Growth" or the "Company") (NYSE: CGC) is pleased to announce that David Klein has been appointed Chair of its Board of Directors effective immediately...
PISCATAWAY, N.J.--(BUSINESS WIRE)-- Solidia Technologies® has named Jules Kortenhorst, CEO of the Rocky Mountain Institute, to its Board of Directors. A world leader on global energy issues and climate change, Kortenhorst ...
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Bridgette Heller to its Board of Directors, effective immediately...
NASHVILLE, Tenn., Sept. 12, 2019 /PRNewswire/ -- ChanceLight Behavioral Health, Therapy and Education, the nation's leading provider of behavioral health, therapy and education solutions for children and young adults, today announced John McLaughlin, Ph.D., has transitioned from ChanceLight Executive Vice President to a member of the Board of Directors...
NEW HAVEN, Conn., Sept. 9, 2019 /PRNewswire/ -- Aeromics, Inc. ("Aeromics" or "the Company"), a privately-held, clinical-stage pharmaceutical company developing first-in-class anti-edema therapies, announced today the appointment of Peter Agre, M.D. to its Board of Directors. Additionally, Dr. Agre will serve as Chair of the newly-formed Science and Technology Subcommittee of the Board of Directors...
JANESVILLE, Wis.--(BUSINESS WIRE)-- SHINE Medical Technologies, LLC today announced the appointment of Paul D. Ryan to the company’s board of directors...
SAN FRANCISCO, Aug. 26, 2019 /PRNewswire/ -- Cricket Health, a comprehensive kidney care provider with a personalized, evidence-based approach to managing care, today announced new additions to the company's senior leadership team. Former health plan leader Colleen Reitan was appointed to the company's board of directors and veteran health care executive Adam Hameed will be joining Cricket Health as chief development officer...
GREENVILLE, S.C., Aug. 26, 2019 /PRNewswire/ -- Chartspan, the largest Chronic Care Management provider in the United States, has announced that Sarath Degala, Senior Vice President of BIP Capital, has been appointed to its new Board of Directors. BIP Capital is the leader of a five investor syndicate group that recently closed a $15 millionSeries A round of venture capital with ChartSpan. ChartSpan plans to use the funds to scale its operations nationally...
Charles (Chuck) Piazza, Accellix's newest board member, has over 35 years of global experience within the life science industry serving the ...
LOS ANGELES--(BUSINESS WIRE)-- Cell BT, Inc. (CBI), an immuno-therapy company focused on the discovery and development of innovative cancer therapeutics based on next generation CAR-T antibody constructs directed to novel biological targets, today announced that Joshua J. Ofman, M.D., MSHS, has been appointed to the CBI Board of Directors...
NEW YORK, July 2, 2019 /PRNewswire/ --Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that Mr. Xiaoming Gao is joining its board of directors...